Insider trades
Tessari Eben, Chief Officer of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 34 sales on the open market. Over the past 12 months that comes to a net sale of $1.5M. The latest trade was on 04/07.
Tessari Eben
Chief Strategy Officer
- First filing
- 23/03/20
- Trades
- 181 trades
- Buys / sales
- 0 / 34
- 12-month net buying
- −$1.5M
- Last trade
- 04/07
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/12/15 | 25/12/17 | 12,048 sh | $41.56 | $500,714.88 | −42.0% | |
| Open-market sale10b5-1 plan | 25/11/26 | 25/12/01 | 200 sh | $42.89 | $8,578 | −0.9% | |
| Open-market sale10b5-1 plan | 25/11/17 | 25/11/19 | 12,470 sh2 trades | $41.24avg. | $514,224.1 | −35.4% | |
| Open-market sale10b5-1 plan | 25/10/14 | 25/10/16 | 12,368 sh2 trades | $37.67avg. | $465,843.22 | −30.1% | |
| Open-market sale10b5-1 plan | 25/09/29 | 25/10/01 | 42,000 sh | $38.33 | $1,609,860 | −54.9% | |
| Open-market sale10b5-1 plan | 25/09/15 | 25/09/17 | 16,400 sh2 trades | $36.46avg. | $597,975.8 | −32.2% | |
| Open-market sale10b5-1 plan | 25/09/04–25/09/05 | 25/09/08 | 98,660 sh2 trades | $35.54avg. | $3,506,277.66 | −68.9% | |
| Open-market sale10b5-1 plan | 25/09/03 | 25/09/03 | 15,091 sh | $35.50 | $535,730.5 | −25.3% | |
| Open-market sale10b5-1 plan | 25/08/18 | 25/08/20 | 16,200 sh2 trades | $33.77avg. | $547,141 | −28.7% | |
| Open-market sale10b5-1 plan | 25/08/05 | 25/08/07 | 138,614 sh2 trades | $33.20avg. | $4,602,369.8 | −73.5% | |
| Open-market sale10b5-1 plan | 25/07/14 | 25/07/16 | 18,900 sh | $28.72 | $542,808 | −27.8% | |
| Open-market sale10b5-1 plan | 25/06/16 | 25/06/18 | 17,300 sh | $28.28 | $489,244 | −21.9% | |
| Open-market sale10b5-1 plan | 25/06/09–25/06/11 | 25/06/11 | 70,867 sh3 trades | $30.48avg. | $2,160,035.4 | −49.5% | |
| Open-market sale10b5-1 plan | 25/05/19 | 25/05/21 | 12,000 sh | $26.41 | $316,920 | −14.2% | |
| Open-market sale10b5-1 plan | 25/04/14 | 25/04/16 | 12,000 sh2 trades | $20.48avg. | $245,811.55 | −13.4% | |
| Open-market sale10b5-1 plan | 25/03/10 | 25/03/12 | 12,409 sh | $21.06 | $261,333.54 | −13.9% | |
| Open-market sale10b5-1 plan | 25/02/10 | 25/02/12 | 14,000 sh | $19.57 | $273,980 | −14.6% | |
| Open-market sale10b5-1 plan | 25/01/13 | 25/01/15 | 14,000 sh2 trades | $18.24avg. | $255,413.15 | −13.6% | |
| Open-market sale10b5-1 plan | 24/12/16 | 24/12/18 | 23,017 sh | $20.44 | $470,467.48 | −19.3% | |
| Open-market sale10b5-1 plan | 24/11/18 | 24/11/20 | 17,000 sh | $21.04 | $357,680 | −14.2% |